Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
Brückner
O
O
Trautmann
M
M
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000188:drug therapy*; D020682:Cefixime / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D016724:Empyema, Pleural / Q000188:drug therapy; D006801:Humans; D015242:Ofloxacin / Q000627:therapeutic use*; D018410:Pneumonia, Bacterial; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012449:Safety; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D020682:Cefixime; D015242:Ofloxacin